OmniComm Systems, Inc. (OmniComm) (OTCQX: OMCM) announced a major milestone achievements for TrialOne. TrialOne is used in a variety of clinics, supporting both healthy and patient driven early phase studies across a multitude of therapeutic areas and study types. Within one yearTrialOne has been deployed in early phase clinics that account for over 1,100 beds, 1,500 users and over 470 clinical studies annually.
TrialOne is the leading proactive eSource and site automation solution for early phase clinical sites. TrialOne is a comprehensive set of modules that drive efficiencies, reduce timelines and decrease costs through faster and more directed volunteer recruitment, easy to build schedule based workflows, real-time bedside data collection, direct data capture from devices, sample processing automation and modern data processing. The browser-based, tablet compatible system provides an advanced platform for automating clinic operations, complies with FDA 21 CFR part 11, and supports data standards such as CDISC for faster and easier exporting and reporting of data.
OmniComm
omnicomm.com
